Global Cancer Screening Market Size to Grow at a CAGR of 9% in the Forecast Period of 2023-2028

The ‘Global Cancer Screening Market Growth, Share, Trend, Size, Analysis, Report and Forecast 2023-2028’ by Expert Market Research gives an extensive outlook of the global cancer screening market, assessing the market on the basis of its segments like cancer type, technique, stage, gender, and major regions.

The report studies the latest updates in the market, along with their impact across the market. It is also analysis the market demand, together with its price and demand indicators. The report also tracks the market on the bases of SWOT and Porter’s Five Forces Models.

Table of Contents

Cancer Screening Market Share, Size, Industry Report, Key Player, Major Segments, and Forecast

The key highlights of the report include:

Market Overview (2018-2028)

• Forecast CAGR (2023-2028): 9%

The increasing prevalence of cancer across the world is leading to an increase in focus on early detection and treatment. Brutal cancers related to blood, lung, and skin, among others, are growing at a robust pace. Unhealthy lifestyles led by the working population, coupled with the increasing number of smokers, are some of the key cancer screening market driving factors. In addition, increasing awareness pertaining to the growing fatalities due to cancer is being witnessed.

Get a Free Sample Report with a Table of Contents@ https://www.expertmarketresearch.com/reports/cancer-screening-market/requestsample

Favorable initiatives by various governments aimed at improving the healthcare infrastructure and curbing cancer cases are further spreading awareness among people about cancer screening. Meanwhile, the growing mergers and collaborations between prominent healthcare firms aimed towards improving timely cancer diagnosis and treatment are providing impetus to the global cancer screening market.

Technological advancements in imaging techniques with high-resolution visualisation devices are expected to increase the efficiency and reliability of cancer screening. The growing sophistication of cancer screening equipment is likely to accelerate the market numbers in the forecast period.

Cancer Screening Industry Definition and Major Segments

Cancer screening is a testing process that aims at detecting cancer at an early stage where there are no active symptoms of cancer, facilitating early treatment, and reducing the risk of fatalities. Cancer screening improves the effectiveness of the cancer treatment process by targeting the growth of cancerous cells at the initial stages.

Read Full Report with Table of Contents@ https://www.expertmarketresearch.com/reports/cancer-screening-market

Based on cancer type, the market can be segmented into:

• Lung Cancer
• Blood Cancer
• Bone Cancer
• Gall Bladder Cancer
• Testicular Cancer
• Thyroid Cancer
• Breast Cancer
• Others

On the basis of technique, the market has been classified into:

• Imaging Techniques
o CT Scan
o MRI
o Others
• Endoscopy
o Colonoscopy
o Sigmoidoscopy
o Others
• Biopsy and Cytology Tests
o Needle Biopsy
o CT – Guided Biopsy
o Others
• Genomic and Molecular tests
o Next Generation Sequencing (NGS)
o RT- PCR
o Others

Based on stage, the market can be categorised into:

• TNM Stages
• Stages 0, 1, 2, 3, 4
• Prognostic Factors
• Others

By gender, the market has been divided into:

• Men
• Women

On the basis of region, the market can be categorised into:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Cancer Screening Market Trends

The key trends in the global cancer screening market include the rising investments and initiatives by various governments towards improving early cancer diagnostics and treatment protocols. Investments in research and development are expected to bring sophistication to mammography, colonoscopy, and MRI, among others. Increasing penetration of artificial intelligence and machine learning can be seen in the market for cancer screening.

The increasing geriatric population is a key trend propelling the cases of lung cancer and bone cancer. Further, favorable regulations by governments are expected to improve the dynamics of the market for cancer screening in the coming years. In geographical terms, North America accounts for a significant share of the cancer screening market. The advanced healthcare infrastructure across strong economies, the prevalence of cancer, and high levels of general awareness regarding cancer are fuelling the growth of the market.

Key Market Players

The major players in the cancer screening market report include:

DiaSorin S.p.A.
Epigenomics AG
Techlab, Inc.
Positive Biosciences Limited
MedGenome Labs Ltd
20/20 GeneSystems
Others

The report covers the market shares, capacities, plant turnarounds, expansions, investments, mergers, and acquisitions, among other latest developments of these market players.